您的购物车当前为空
HFI-142 是一种小分子抑制剂,能够特异性结合氨肽酶 N 的活性位点并抑制其酶活性。HFI-142 已被证明可抑制红细胞中白三烯 A4 的生物合成,该作用通过调控与肿瘤生长和进展相关的炎症及代谢通路,可能在癌症研究中具有治疗潜力。HFI-142 还可抑制其他氨肽酶的活性,包括氨肽酶 N 以及与蛋白质代谢相关的多种酶。


为众多的药物研发团队赋能,
让新药发现更简单!
HFI-142 是一种小分子抑制剂,能够特异性结合氨肽酶 N 的活性位点并抑制其酶活性。HFI-142 已被证明可抑制红细胞中白三烯 A4 的生物合成,该作用通过调控与肿瘤生长和进展相关的炎症及代谢通路,可能在癌症研究中具有治疗潜力。HFI-142 还可抑制其他氨肽酶的活性,包括氨肽酶 N 以及与蛋白质代谢相关的多种酶。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 652 | In stock | |
| 5 mg | ¥ 1,080 | 6-8周 | |
| 10 mg | ¥ 1,800 | 6-8周 | |
| 50 mg | ¥ 5,320 | 6-8周 | |
| 100 mg | ¥ 8,150 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,920 | 6-8周 |
HFI-142 相关产品
| 产品描述 | HFI-142 is a small-molecule inhibitor that binds specifically to the active site of aminopeptidase N and suppresses its enzymatic activity. HFI-142 has been demonstrated to inhibit leukotriene A4 biosynthesis in red blood cells, an effect that may offer therapeutic potential for the research in cancer by modulating inflammatory and metabolic pathways implicated in tumor growth and progression. HFI-142 was also shown to inhibit the activity of additional aminopeptidases, including aminopeptidase N, as well as other enzymes associated with protein metabolism. |
| 靶点活性 | IRAP:2.01 μM (ki) |
| 分子量 | 312.32 |
| 分子式 | C17H16N2O4 |
| CAS No. | 332164-34-8 |
| Smiles | O=C(OCC)C1=C(OC2=CC(O)=CC=C2C1C=3C=NC=CC3)N |
| 密度 | 1.334 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (320.18 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (12.81 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容